First U.S. use of CRISPR to directly target cancer seeks approval

Re:First U.S. use of CRISPR to directly target cancer seeks ... by ekianjo on Thursday June 13, 2019 @06:49AM (#20173477)

> I'm really frustrated with how little effort has been devoted to cancer research in such a long period of time

It may seem slow but for a while now most of research budgets and acquisitions are for oncology. And still now most pharma companies are engaging a majority of their r and d spending into oncology.

[ Parent | on HN ]

Re:First U.S. use of CRISPR to directly target cancer seeks ... by happy-go-lucky on Thursday June 13, 2019 @08:49AM (#20174267)

I may sound cynical, but I wonder if pharma companies would ever be interested in search for a cure for a malignancy or other deadly disease. Wouldn’t it be harming their own interests?

[ Parent | on HN ]

Re:First U.S. use of CRISPR to directly target cancer seeks ... by jcranmer on Thursday June 13, 2019 @09:58AM (#20174895)

Why would a profit-driven company turn away curing the second leading cause of death? It's a market whose yearly demand is going to be in the tens to hundreds of thousands in the US alone, even if you're only going to be on the drug for a short amount of time.

[ Parent | on HN ]

Re:First U.S. use of CRISPR to directly target cancer seeks ... by shadowtree on Friday June 14, 2019 @04:56PM (#20186614)

Hep-C is now curable. Wasn't 10 years ago.

You're wrong.

An insulin company will not cure diabetes - but a startup looking to disrupt them will. Circle of life/business, in pharma like elsewhere.

[ Parent | on HN ]

Re:First U.S. use of CRISPR to directly target cancer seeks ... by ekianjo on Thursday June 13, 2019 @08:10PM (#20179650)

If that were true no pharma company would ever develop vaccines. Yet it is not the case.

[ Parent | on HN ]